North Ridge Wealth Advisors’s Merck MRK Stock Holding History

North Ridge Wealth Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-264	Closed	-$26.3K	–	185
2024 Q4	$26.3K	Buy	+264	New	+$27.2K	0.02%	92

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

North Ridge Wealth Advisors's MRK Position: Q1 2025 in Review

North Ridge Wealth Advisors sold out of Merck (MRK) in Q1 2025, closing a stake of 264 shares — an estimated $26.3K sold.

North Ridge Wealth Advisors first reported a position in MRK in Q4 2024 and held it in 1 quarter. The position peaked at $26.3K in Q4 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

North Ridge Wealth Advisors reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
North Ridge Wealth Advisors sold 264 Merck shares in Q1 2025, an estimated $26.3K.
North Ridge Wealth Advisors first reported a position in Merck in Q4 2024 and held it in 1 quarter.
North Ridge Wealth Advisors's Merck position peaked at $26.3K in Q4 2024.
3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on North Ridge Wealth Advisors's 13F filing for Q1 2025, filed 9 May 2025.